Effect of Splenectomy on Type-1/type-2 Cytokine Gene Expression in a Patient with Adult Idiopathic Thrombocytopenic Purpura (ITP)
Overview
Authors
Affiliations
BACKGROUND: In view of clinical observations and laboratory results that support a central role of the spleen in idiopathic thrombocytopenic purpura (ITP) pathophysiology, we studied the effect of splenectomy on type-1 and type-2 cytokine gene expression in an adult ITP case, refractory to conservative treatment. CASE PRESENTATION: The patient was subjected to splenectomy 9 months after the diagnosis with complete response, attaining platelet counts over 150 x 106/L within 10 days after the operation. Two consecutive blood samples were obtained from the patient, 3 and 7 months after the splenectomy for the purposes of this study. A control group consisted of 11 healthy adults. Peripheral blood mononuclear cells were prepared from each blood sample and cultured in vitro for 8 h with the addition of the mitogens phorbol myristate acetate and ionomycin. Total cellular RNA extracted from 106 cells was submitted to semiquantitave reverse transcriptase-polymerase chain reaction (RT-PCR) for the amplification of IL-2, IFN-gamma, IL-4, IL-5, and IL-10 metagraphs. The PCR products were run on ethidium-stained agarose gels, photographed and quantified by densitometry.A steep decrease of type-1 cytokine expression (IL-2, IFN-gamma) and their calculated sum expressing Th1 activity was observed at 7 months post-splenectomy compared to 3 months post-splenectomy, in parallel with a rise of platelet count from 190 x 106/L to 265 x 106/L. The change of type-2 cytokine expression (IL-4, IL-5, IL-10) was slight and the Th2 activity (IL-4+IL-5) remained largely unchanged. The Th1/Th2 ratio, that reflects the pathogenic disease-specific T-cell immune deviation, was accordingly reduced 7 months post-splenectomy (Th1/Th2 = 1.3) compared to 3 months (Th1/Th2 = 3.5). CONCLUSIONS: The reduction of the Th1/Th2 cytokine ratio that was observed over time after splenectomy was accompanied by full clinical remission. Nevertheless, the persistence of a type-1 polarization, even after several months following spleen removal, is suggestive of a more basic abnormality of the immune function in these patients.
Emerging Concepts in Immune Thrombocytopenia.
Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek F, Jansen A Front Immunol. 2018; 9:880.
PMID: 29760702 PMC: 5937051. DOI: 10.3389/fimmu.2018.00880.
Zhou S, Ma J, Qu H, Liu Z, He W, Wang J J Clin Immunol. 2013; 33(5):938-46.
PMID: 23494742 DOI: 10.1007/s10875-013-9883-4.
Chen X, Chen S, Li C, Zhu Y, Peng B Int J Hematol. 2011; 94(3):248-254.
PMID: 21858445 DOI: 10.1007/s12185-011-0908-6.